Inventiva (IVA) Other Non-Current Assets (2018 - 2025)
Inventiva (IVA) posted quarterly Other Non-Current Assets of $1.4 million for Q4 2025, up 20.9% year-over-year from $1.1 million in Q4 2024, and down 99.89% quarter-over-quarter from $1.2 billion in Q2 2025.
Analysis
Inventiva (IVA) Other Non-Current Assets (2018 - 2025) Analysis & Trends
Inventiva's Other Non-Current Assets history runs 8 years deep, the most recent figure standing at $1.4 million for Q4 2025.
- In Q4 2025, Other Non-Current Assets rose 20.9% year-over-year to $1.4 million; the TTM figure through Dec 2025 stood at $1.4 million (up 20.9% YoY), while the FY2025 annual figure was $1.4 million, up 20.9% from the prior year.
- Other Non-Current Assets for Q4 2025 stood at $1.4 million, down from $1.2 billion in the prior quarter.
- The five-year high for Other Non-Current Assets was $1.7 billion in Q2 2022, with the low at $1.1 million in Q4 2024.
- The 5-year median for Other Non-Current Assets is $3.3 million (2021), against an average of $269.2 million.
- The sharpest annual moves came in 2023 and 2025: Other Non-Current Assets tumbled 99.36% in 2023, then soared 105014.01% in 2025.
- Inventiva's Other Non-Current Assets stood at $2.8 million in 2021, then plunged by 39.08% to $1.7 million in 2022, then surged by 538.57% to $10.9 million in 2023, then sank by 89.7% to $1.1 million in 2024, then grew by 20.9% to $1.4 million in 2025.
- Business Quant data shows IVA's Other Non-Current Assets at $1.4 million in Q4 2025, $1.2 billion in Q2 2025, and $1.1 million in Q4 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 1.25 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 2.31 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 124.00 Mn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 618.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 42.45 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 109.58 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 65.13 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 62.96 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 104.44 Mn |
| 10 | Inventiva | 893.85 Mn | 893.85 Mn | - | 1.35 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 1.35 Mn |
| Jun 30, 2025 | 1.19 Mn |
| Dec 31, 2024 | 1.12 Mn |
| Jun 30, 2024 | 15.67 Mn |
| Dec 31, 2023 | 10.82 Mn |
| Jun 30, 2023 | 11.20 Mn |
| Dec 31, 2022 | 1.70 Mn |
| Jun 30, 2022 | 1.74 Mn |
| Dec 31, 2021 | 2.79 Mn |
| Jun 30, 2021 | 4.15 Mn |
| Mar 31, 2021 | 3.32 Mn |
| Dec 31, 2020 | 2.03 Mn |
| Jun 30, 2020 | 4.56 Mn |
| Dec 31, 2019 | 3.47 Mn |
| Dec 31, 2018 | 2.71 Mn |